Pre-transplant antibodies against SNRPB2 were significantly positively associated with late ABMR, prior only associated with the recurrence of focal segmental glomerulosclerosis in kidney transplants [44]. The gene discussed is SNRPB2; the disease is focal segmental glomerulosclerosis.